Association of Diuretic Dosage With Outcomes in Patients With Hemodynamically Significant Isolated Tricuspid Valve Regurgitation
A daily loop diuretic dose ≥40 mg furosemide equivalent is associated with increased mortality and greater symptom severity in patients with TR.
Authors
- Sorin V. Pislaru (ORCID: https://orcid.org/0000-0002-5256-3150)
- Daniel D. Borgeson
- Garvan C. Kane (ORCID: https://orcid.org/0000-0002-4308-6356)
- Patricia A. Pellikka (ORCID: https://orcid.org/0000-0001-6800-3521)
- Jeremy J. Thaden (ORCID: https://orcid.org/0000-0003-4489-2349)
- Barry A. Borlaug (ORCID: https://orcid.org/0000-0001-9375-0596)
- Cristina Pislaru (ORCID: https://orcid.org/0000-0003-3820-0473)
- Juan A. Crestanello (ORCID: https://orcid.org/0000-0001-5415-1478)
- Mackram F. Eleid (ORCID: https://orcid.org/0000-0001-6082-5379)
- Vuyisile T. Nkomo (ORCID: https://orcid.org/0000-0001-6095-5579)
- Christopher G. Scott (ORCID: https://orcid.org/0000-0003-1340-0647)
- Vidhu Anand (ORCID: https://orcid.org/0009-0006-7580-1314)
- Khaled A. Ali
Institutions
- WinnMed (US)
- Mayo Clinic Health System (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1161/jaha.124.039989
- Citations
- 1
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39